1 – 55 of 55
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Potential diagnostic and drug target markers in glioblastoma
(
- Contribution to journal › Article
-
Mark
Dynamics of Mitochondrial Proteome and Acetylome in Glioblastoma Cells with Contrasting Metabolic Phenotypes
(
- Contribution to journal › Article
-
Mark
Dichotomous Effects of Glypican-4 on Cancer Progression and Its Crosstalk with Oncogenes
(
- Contribution to journal › Article
-
Mark
Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth
(
- Contribution to journal › Article
- 2023
-
Mark
Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy
(
- Contribution to journal › Article
-
Mark
Tracking cell turnover in human brain using 15N-thymidine imaging mass spectrometry
(
- Contribution to journal › Article
-
Mark
Complement Components in Peripheral Blood from Adult Patients with IDH Wild-Type Glioblastoma
(
- Contribution to journal › Article
-
Mark
Brain Tumor Imaging and Treatment Effects. Imaging findings and cognitive function in glioblastoma patients.
2023) In Lund University, Faculty of Medicine Doctoral Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Distinct Cholesterol Localization in Glioblastoma Multiforme Revealed by Mass Spectrometry Imaging
(
- Contribution to journal › Article
-
Mark
Antisecretory factor is safe to use as add-on treatment in newly diagnosed glioblastoma
(
- Contribution to journal › Article
-
Mark
Combined anti-C1-INH and radiotherapy against glioblastoma
(
- Contribution to journal › Article
-
Mark
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma
(
- Contribution to journal › Article
-
Mark
Predictive value of diffusion MRI-based parametric response mapping for prognosis and treatment response in glioblastoma
(
- Contribution to journal › Article
- 2022
-
Mark
Adaptation to microenvironmental stress in glioblastoma. Mechanistic studies and potential targets.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Novel methods of malignant brain tumor treatment utilizing the tumor microenvironment
2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Emerging Roles of DLK1 in the Stem Cell Niche and Cancer Stemness
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Stromal and tumor cell responses to hypoxia and treatment within the glioma microenvironment
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Terminally sialylated and fucosylated complex N-glycans are involved in the malignant behavior of high-grade glioma
(
- Contribution to journal › Article
-
Mark
What is the role of CRP in glioblastoma?
(
- Contribution to journal › Article
-
Mark
A randomized phase II trial of efficacy and safety of the immunotherapy ALECSAT as an adjunct to radiotherapy and temozolomide for newly diagnosed glioblastoma
(
- Contribution to journal › Article
- 2020
-
Mark
Novel treatments of glioblastoma in experimental models
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma
(
- Contribution to journal › Article
-
Mark
Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T
(
- Contribution to journal › Article
-
Mark
Driving Neuronal Differentiation through Reversal of an ERK1/2-miR-124-SOX9 Axis Abrogates Glioblastoma Aggressiveness
(
- Contribution to journal › Article
-
Mark
Global extracellular vesicle proteomic signature defines U87-MG glioma cell hypoxic status with potential implications for non-invasive diagnostics
(
- Contribution to journal › Article
-
Mark
Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients
(
- Contribution to journal › Article
-
Mark
Feasibility of multi-parametric PET and MRI for prediction of tumour recurrence in patients with glioblastoma
(
- Contribution to journal › Article
- 2018
-
Mark
Anti-C1-inactivator treatment of glioblastoma
(
- Contribution to journal › Article
-
Mark
Evaluating vacquinol-1 in rats carrying glioblastoma models RG2 and NS1
(
- Contribution to journal › Article
-
Mark
Augmenting Glioblastoma Chemotherapy with Polymers
(
- Contribution to journal › Scientific review
-
Mark
Combined Proteomic-Molecular Epidemiology Approach to Identify Precision Targets in Brain Cancer
(
- Contribution to journal › Article
-
Mark
Large Scale Identification of Variant Proteins in Glioma Stem Cells
(
- Contribution to journal › Article
- 2017
-
Mark
Radiotherapy induces an immediate inflammatory reaction in malignant glioma : a clinical microdialysis study
(
- Contribution to journal › Article
-
Mark
Identification of two distinct mesenchymal stromal cell populations in human malignant glioma
(
- Contribution to journal › Article
-
Mark
C1-inactivator is upregulated in glioblastoma
(
- Contribution to journal › Article
-
Mark
Adaptive mechanisms in the hypoxic tumor microenvironment. Functional role of proteoglycans and identification of potential treatment targets
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
(
- Contribution to journal › Article
-
Mark
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
(
- Contribution to journal › Article
- 2015
-
Mark
Mesenchymal stromal cells in malignant glioma - Functions and therapeutic potential
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Adaptive mitochondrial reprogramming and resistance to PI3K therapy
(
- Contribution to journal › Article
-
Mark
Tapasin is a key component to understand immunogenicity in glioblastoma
(
- Contribution to conference › Poster
- 2014
-
Mark
Mechanistic studies on the role of extracellular vesicles in the tumor microenvironment
(
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Mechanistic Studies On the Role of Polyamines and Microvesicles in Tumor Growth and Hypoxia-mediated Angiogenesis
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Further characterisation of the cellular activity of the DNA-PK inhibitor, NU7441, reveals potential cross-talk with homologous recombination
(
- Contribution to journal › Article
- 2011
-
Mark
Network modeling of the transcriptional effects of copy number aberrations in glioblastoma
(
- Contribution to journal › Article
-
Mark
MOLECULAR ASPECTS OF ENDOTHELIAL CELL FUNCTION AND HYPOXIA-DEPENDENT TUMOR ANGIOGENESIS
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Human immunoglobulin G levels of viruses and associated glioma risk
(
- Contribution to journal › Article
- 2010
-
Mark
Optical Touch Pointer for Fluorescence Guided Glioblastoma Resection Using 5-Aminolevulinic Acid
(
- Contribution to journal › Article
-
Mark
Glycomic and transcriptomic response of GSC11 glioblastoma stem cells to STAT3 phosphorylation inhibition and serum-induced differentiation
(
- Contribution to journal › Article
-
Mark
Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network : an initial study in GSC11 glioblastoma stem cells
(
- Contribution to journal › Article
- 2008
-
Mark
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)
(
- Contribution to journal › Article
- 2007
-
Mark
Method for lipidomic analysis : p53 expression modulation of sulfatide, ganglioside, and phospholipid composition of U87 MG glioblastoma cells
(
- Contribution to journal › Article
-
Mark
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression
(
- Contribution to journal › Article
- 2005
-
Mark
HAMLET - In vivo effects and mechanisms of tumor-cell death
2005) In New England Journal of Medicine, Cancer Research(
- Thesis › Doctoral thesis (compilation)
-
Mark
HAMLET; a novel tool to identify apoptotic pathways in tumor cells.
2005) p.223-245(
- Chapter in Book/Report/Conference proceeding › Book chapter